Innoviva share price logo

Innoviva

NASDAQ: INVA

Small Cap

$21.07

+0.07

(+0.33%)

as on

Innoviva Stock Performance

as on August 22, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $20.89
    $21.23
    downward going graph

    0.85%

    Downside

    0.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $16.52
    $25.15
    downward going graph

    21.59%

    Downside

    19.34%

    Upside

    downward going graph

Innoviva share price movements today

Previous Close
$21.00
Open
$20.96
Volume
381.8K
Market Cap
$1.5B
Day's Low - High
$20.89 - $21.23
52 Week Low - High
$16.52 - $25.15

Innoviva Historical Returns

1 Month Return
-2.4 %
3 Month Return
-3.55 %
1 Year Return
+ 1.29 %
3 Year Return
+ 56.15 %
5 Year Return
+ 28.35 %

Innoviva Stock Fundamentals & Key Indicators

Check Innoviva market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

4.87

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

5.90%

PE Ratio (TTM)

4.26

Industry PE ratio

-7.283372093023256

PEG Ratio

0.0061011173130501

EBITDA

823.3M

Revenue (TTM)

443.4M

Profit Margin

73.09%

Return On Equity TTM

30.03%

Innoviva Stock Valuation

Track how Innoviva P/E has moved over time to understand its valuation trends.

Innoviva in the last 5 years

  • Overview

  • Trends

Lowest (4.31x)

December 31, 2022

Industry (-7.28x)

December 31, 2025

Today (4.97x)

December 31, 2025

Highest (46.89x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 4.97x

Innoviva vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Innoviva with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$1.5B28.35%4.2673.09%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Innoviva Stock including INR - Dollar returns

The Innoviva stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Innoviva investment value today

Current value as on today

₹1,10,380

Returns

₹10,380

(+10.38%)

Returns from Innoviva Stock

₹717 (+0.72%)

Dollar Impact

₹9,663 (+9.66%)

Analyst Recommendation on Innoviva Stock

Based on 3 analysts

SELL

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'SELL' rating for Innoviva. Average target price of $35

Innoviva Share Price Target

Get share price movements and forecasts by analysts on Innoviva.

What analysts predicted

39.8%UPSIDE

Target Price

$35

Current Price

$21.07

Analyzed by

3 Analysts

Target

$35.00

Innoviva target price $35, a slight upside of 39.8% compared to current price of $21.07. According to 3 analysts rating.

Indian Investors' Interest in Innoviva Stock

Search interest for Innoviva Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Innoviva Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
77
103
89
91
88
100
107
118
97
119
Gross Profit
66
84
79
84
79
89
82
75
75
90
Operating Income
25
54
49
43
-41
-48
34
38
38
50
EBITDA
57
-23
19
35
-27
83
108
208
239
267
Interest Expense
5
5
5
4
4
4
4
3
5
5
Depreciation
6
9
6
6
6
6
6
10
10
62
Income Before Tax
45
-39
6
24
-38
72
97
195
234
-108
Income Tax Expense
8
-4
5
4
7
8
7
30
47
-24
Net Income
36
-34
1
20
-46
63
89
164
186
-83
Net Profit Margin
85.84%
82.21%
88.84%
92.20%
90.02%
89.44%
76.09%
64.05%
77.39%
75.77%

Innoviva Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
217
261
261
336
391
331
310
358
425
Gross Profit
215
261
261
336
391
317
267
322
307
Operating Income
183
238
246
321
375
206
113
166
163
EBITDA
205
248
260
372
478
308
235
85
383
Interest Expense
43
23
18
18
19
15
19
22
16
Depreciation
13
13
13
-
13
5
21
25
40
Income Before Tax
134
210
232
354
445
286
194
37
326
Income Tax Expense
0
-196
41
60
76
66
14
13
55
Net Income
134
395
157
224
265
213
179
23
271
Net Profit Margin
99.38%
100.00%
100.00%
100.00%
100.00%
95.84%
86.27%
89.80%
72.33%

Innoviva Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
36
-34
1
20
-46
63
89
241
186
-83
Operating Cash Flow
37
43
48
59
48
44
49
54
35
51
Investing Cash Flow
-43
-
-5
-15
-34
33
18
23
37
-55
Financing Cash Flow
-9
-5
0
0
0
1
10
-3
-20
-29
Change in Cash
-15
38
43
44
14
78
78
74
52
-32

Innoviva Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
134
406
190
293
368
220
179
23
271
Operating Cash Flow
141
223
257
313
363
201
141
188
196
Investing Cash Flow
-23
3
-18
-314
43
-56
-66
-63
40
Financing Cash Flow
-163
-237
-23
-29
-452
-55
-171
-13
8
Change in Cash
-44
-10
215
-31
-44
89
-97
111
245

Mutual Funds that own Innoviva Stock

Check out the Mutual Funds with significant holdings in Innoviva.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
7.857602%
5676763
DFA INVESTMENT DIMENSIONS GROUP INC
3.384795%
2445362
Fidelity Salem Street Trust
1.124792%
812612
Fidelity Concord Street Trust
0.998043%
721041
TIAA-CREF Funds
0.906467%
654882

Global Institutional Holdings in Innoviva

Funds
Holdings
iShares
11.5%
Vanguard
9.58%
Dimensional
2.44%
SPDR
2.36%
Avantis
1.7%

Insights on Innoviva

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 97.99M → 119.59M (in $), with an average increase of 18.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 461.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 570.7% return, outperforming this stock by 512.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, INVA stock has moved down by -0.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 186.59M → -83.42M (in $), with an average decrease of 144.7% per quarter

About Innoviva

Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and an inhaled corticosteroid, and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, and ABA, VI. The company also markets GIAPREZA for increasing blood pressure in adults with septic or other distributive shock; XACDURO, a co-packaged for intravenous use for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia caused by Acinetobacter; XERAVA for the treatment of complicated intra-abdominal infections in adults; ZEVTERA an advanced-generation cephalosporin antibiotic for the treatment of staphylococcus aureus bacteremia, as well as with right-sided endocarditis, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia; NUZOLVENCE for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents. In addition, the company develops bacteriophages with potential use in a range of infectious and other serious diseases. It has a strategic partnership with Sarissa Capital Management LP; and LABA Collaboration Agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
OrganisationInnoviva
Headquarters1350 Old Bayshore Highway, Burlingame, CA, United States, 94010
IndustryBiotechnology
CEOMr. Pavel Raifeld C.F.A.
E-voting on sharesClick here to vote

Key Management of Innoviva

Name

Title

Ms. Marianne Zhen CPA

Chief Accounting Officer & Secretary

Ms. Patricia M. Drake

Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.

Dr. David Altarac M.D., MPA

Chief Medical Officer of IST

Mr. Pavel Raifeld C.F.A.

CEO & Director

Mr. Stephen Basso M.B.A.

Chief Financial Officer

FAQs

What is Innoviva share price today?

Innoviva share price today is $21.07 as on at the close of the market. Innoviva share today touched a day high of $21.23 and a low of $20.89.

What is the 52 week high and 52 week low for Innoviva share?

Innoviva share touched a 52 week high of $25.15 on and a 52 week low of $16.52 on . Innoviva stock price today i.e. is closed at $21.07,which is 16.21% down from its 52 week high and 27.54% up from its 52 week low.

What is Innoviva's market capitalisation today?

Innoviva market capitalisation is $0.00T as on .

How to invest in Innoviva Stock (INVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Innoviva on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Innoviva Shares that will get you 0.0712 shares as per Innoviva share price of $21.07 per share as on August 22, 2026 at 8:45 am IST.

What is the minimum amount required to buy Innoviva Stock (INVA) from India?

Indian investors can start investing in Innoviva (INVA) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in Innoviva stock (as per the Rupee-Dollar exchange rate as on ). Based on Innoviva share’s latest price of $21.07 as on August 22, 2026 at 8:45 am IST, you will get 0.4746 shares of Innoviva. Learn more about fractional shares .

What are the returns that Innoviva has given to Indian investors in the last 5 years?

Innoviva stock has given 28.35% share price returns and 29.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?